ISRG
Intuitive Surgical Inc.
$438.10
-$1.70(-0.39%)
41
Overall
30
Value
27
Tech
68
Quality
Market Cap
$159.93B
Volume
2.01M
52W Range
$417.74 - $603.88
Target Price
$583.23
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $2.7B | $3.1B | $3.7B | $4.5B | $4.4B | $5.7B | $6.2B | $7.1B | $8.4B | $10.1B | ||
| Total Revenue | $2.7B | $3.1B | $3.7B | $4.5B | $4.4B | $5.7B | $6.2B | $7.1B | $8.4B | $10.1B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $814.3M | $936.2M | $1.1B | $1.4B | $1.5B | $1.8B | $2.0B | $2.4B | $2.7B | $3.4B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $1.9B | $2.2B | $2.6B | $3.1B | $2.9B | $4.0B | $4.2B | $4.7B | $5.6B | $6.6B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $944.9M | $1.1B | $1.4B | $1.7B | $1.8B | $2.1B | $2.6B | $3.0B | $3.3B | $3.7B | ||
| Research & Development | $239.6M | $328.6M | $418.1M | $557.3M | $595.1M | $671.0M | $879.0M | $998.8M | $1.1B | $1.3B | ||
| Research Expense | $239.6M | $328.6M | $418.1M | $557.3M | $595.1M | $671.0M | $879.0M | $998.8M | $1.1B | $1.3B | ||
| Selling, General & Administrative | $705.3M | $810.5M | $986.6M | $1.2B | $1.2B | $1.5B | $1.7B | $2.0B | $2.1B | $2.4B | ||
| General & Administrative Expenses | $705.3M | $810.5M | $986.6M | $1.2B | $1.2B | $1.5B | $1.7B | $2.0B | $2.1B | $2.4B | ||
| Salaries & Wages | $-56.1M | $-49.2M | $-54.3M | $-70.2M | $-81.4M | $-93.7M | -- | -- | -- | -- | ||
| Depreciation & Amortization | $70.7M | $82.1M | $105.9M | $156.7M | $221.0M | $280.0M | $326.0M | $382.0M | $439.0M | -- | ||
| Depreciation & Amortization | $70.7M | $82.1M | $105.9M | $156.7M | $221.0M | $280.0M | -- | -- | -- | -- | ||
| Amortization | $18.2M | $201.1M | $240.6M | $307.2M | $336.7M | $343.6M | $348.5M | $348.7M | $347.5M | -- | ||
| Other Operating Expenses | $-29.9M | $-21.1M | $-22.5M | $-26.5M | $-40.1M | $-40.6M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $945.2M | $1.1B | $1.2B | $1.4B | $1.0B | $1.8B | $1.6B | $1.8B | $2.3B | $2.9B | ||
| EBITDA | $1.1B | $1.2B | $1.4B | $1.7B | $1.3B | $2.1B | $2.0B | $2.0B | $2.7B | $3.3B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Intinc | -- | -- | -- | -- | -- | -- | -- | -- | $324.9M | -- | ||
| Net Non-Operating Interest Income/Expense | -- | -- | -- | -- | -- | -- | $-29.7M | $-192.1M | $324.9M | -- | ||
| Gain on Sale of Securities | -- | -- | $-9.8M | $20.4M | $29.5M | $-16.0M | -- | -- | -- | -- | ||
| Other Income/Expense | $-35.6M | $-41.9M | $-80.1M | $-127.7M | $-157.2M | $-69.3M | $-29.7M | $-192.1M | $-324.9M | $-365.9M | ||
| Other Special Charges | $35.6M | $41.9M | $80.1M | $127.7M | $157.2M | $69.3M | $29.7M | $192.1M | $324.9M | $365.9M | ||
| SPECIAL ITEMS | ||||||||||||
| Special Income Charges | -- | $-11.7M | $42.5M | $42.5M | -- | -- | $-28.1M | -- | $-21.2M | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $980.8M | $1.1B | $1.3B | $1.5B | $1.0B | $1.8B | $1.6B | $2.0B | $2.7B | $3.3B | ||
| Pre-Tax Income | $980.8M | $1.1B | $1.3B | $1.5B | $1.2B | $1.9B | $1.6B | $2.0B | $2.7B | $3.3B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $244.9M | $433.9M | $154.5M | $120.4M | $140.2M | $162.2M | $262.4M | $141.6M | $336.3M | $434.8M | ||
| NET INCOME | ||||||||||||
| Net Income | $735.9M | $670.9M | $1.1B | $1.4B | $1.1B | $1.7B | $1.3B | $1.8B | $2.3B | $2.9B | ||
| Net Income (Continuing Operations) | $735.9M | $670.9M | $1.1B | $1.4B | $1.1B | $1.7B | $1.3B | $1.8B | $2.3B | $2.9B | ||
| Net Income (Discontinued Operations) | $735.9M | $670.9M | $1.1B | $1.4B | $1.1B | $1.7B | $1.3B | $1.8B | $2.3B | $2.9B | ||
| Net Income (Common Stockholders) | $735.9M | $671.3M | $1.1B | $1.4B | $1.1B | $1.7B | $1.3B | $1.8B | $2.3B | $2.9B | ||
| Normalized Income | $636.6M | $718.1M | $1.0B | $1.2B | $1.0B | -- | -- | -- | -- | $3.3B | ||
| TOTALS | ||||||||||||
| Total Expenses | $1.8B | $2.1B | $2.5B | $3.1B | $3.3B | $3.9B | $4.6B | $5.4B | $6.0B | $7.1B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $344.7M | $335.1M | $341.1M | $346.2M | $351.0M | $356.1M | $355.7M | $351.2M | $355.2M | $356.9M | ||
| Average Shares Outstanding (Diluted) | $353.7M | $348.9M | $356.4M | $358.5M | $360.9M | $365.8M | $362.0M | $357.4M | $362.0M | $362.7M | ||
| Shares Outstanding | $349.1M | $336.9M | $343.5M | $348.0M | $353.2M | $357.7M | $350.4M | $352.3M | $356.7M | $355.1M | ||
| Basic EPS | $2.13 | $1.97 | $3.31 | $3.98 | $3.02 | $4.79 | $3.72 | $5.12 | $6.54 | $8 | ||
| Basic EPS (Continuing Operations) | $2.13 | $1.97 | $3.31 | $3.98 | $3.02 | $4.79 | $3.72 | $5.12 | $6.54 | $8 | ||
| Diluted EPS | $2.08 | $1.89 | $3.16 | $3.85 | $2.94 | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 | ||
| Diluted EPS (Continuing Operations) | $2.08 | $1.89 | $3.16 | $3.85 | $2.94 | $4.66 | $3.65 | $5.03 | $6.42 | $7.87 | ||
| OTHER METRICS | ||||||||||||
| Acquisition Expense | -- | -- | -- | -- | $53.1M | $71.8M | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | $900.0K | $-2.9M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Minority Interests | $5.8B | $400.0K | $2.9M | $-2.5M | $-6.2M | $-23.5M | $-22.1M | $-19.3M | $-14.9M | $-20.6M | ||
| Non Recurring Operation Expense | -- | $11.7M | $-42.5M | $-42.5M | -- | -- | -- | -- | -- | -- | ||
| Other Gand A | $705.3M | $810.5M | $986.6M | $1.2B | $1.2B | $1.5B | $1.7B | $2.0B | $2.1B | $2.4B | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ISRG | $438.10 | -0.4% | 2.01M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |